The
blood-brain barrier blocks the development of biologic pharmaceuticals
for brain
ArmaGen provides
platform technology solutions to the 'blood-brain barrier' problem,
and can non-invasively target recombinant proteins, therapeutic
monoclonal antibodies, and siRNA to the brain
|
Brain
blood vessels form the blood-brain barrier and block drug access
to the brain
|
| News
March 14, 2008 |
ArmaGen
Receives Notice of Allowance
Patent
claims allowed. The U.S. Patent and
Trademark Office has granted a Notice of Allowance
on Delivery of Pharmaceutical Agents Via the Human
Insulin Receptor. The patent claims cover the
genetic engineering of a monoclonal antibody (MAb)
against the human insulin receptor (HIR). The HIRMAb
acts as a molecular Trojan horse to ferry drugs across
the human blood-brain barrier (BBB).......
|
|
|
